Aarkstore Enterprise Allergic Conjunctivitis - Pipeline Assessment and Market Forecasts to 2017 by aarkstore

VIEWS: 4 PAGES: 2

More Info
									Aarkstore Enterprise Allergic Conjunctivitis - Pipeline Assessment and Market Forecasts to
2017

                   Summary

                   , the industry analysis specialist, has released its new report, “Allergic
                   Conjunctivitis - Pipeline Assessment and Market Forecasts to 2017”. The
                   report is an essential source of information and analysis on the global allergic
                   Conjunctivitis market. The report identifies the key trends shaping and
                   driving the global allergic Conjunctivitis market. The report also provides
                   insights on the prevalent competitive landscape and the emerging players
                   expected to significantly alter the market positioning of the current market
                   leaders. Most importantly, the report provides valuable insights on the
                   pipeline products within the global allergic Conjunctivitis sector. This report
                   is built using data and information sourced from proprietary databases,
                   primary and secondary research and in-house analysis by ’s team of industry
experts.

estimated the allergic conjunctivitis market in 2009 to be worth $1,327m. Allergic conjunctivitis
is the most common type of eye allergy and is widely experienced by the global population. The
incidence appears to be on the increase, possibly due to air pollution and allergens worldwide.
The global allergic conjunctivitis market in 2009 primarily consisted of drug classes which
included anti-histamines and mast cell stabilizers. The market remains well-served with more
than five products, which are significantly efficacious in their respective target areas. Overall,
between 2009 and 2017, the allergic conjunctivitis market is expected to grow at a Compound
Annual Growth Rate (CAGR) of only 4.4% and reach $1,867m by 2017.

Scope

The report provides information on the key drivers and challenges of the allergic Conjunctivitis
market. Its scope includes:
- Annualized global allergic Conjunctivitis market revenues data from 2001 to 2009, forecast for
eight years to 2017.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being
developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as
histamine antagonist and mast cell stabilizers, immune system modulators, glucocorticoid
receptor antagonists and Leutocyte elastate inhibitors.

For more information please visit link:

http://www.aarkstore.com/reports/Allergic-Conjunctivitis-Pipeline-Assessment-and-Market-
Forecasts-to-2017-12387.html

Neel
Aarkstore Enterprise
Phone:08149852585
Email:enquiry@aarkstore.com
URL:www.aarkstore.com

More Reports

Benign Prostatic Hyperplasia (BPH) Therapeutics - Pipeline Assessment and Market Forecasts to
2017
Allergic Conjunctivitis - Pipeline Assessment and Market Forecasts to 2017
Fibromyalgia Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Assessment and Market Forecasts to
2017
Endometriosis - Pipeline Assessment and Market Forecasts to 2017
Dystonia - Pipeline Assessment and Market Forecasts to 2017

								
To top